Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Free Cash Flow Generation Index
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Free Cash Flow Generation Index of 0.81x as of September 2025. Free cash flow of CN¥89.71 Million represents 1% of operating cash flow (CN¥110.78 Million). Explore capital reinvestment ratio of Tianjin Zhongxin Pharmaceutical Group Co to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Free Cash Flow Generation Index (2001–2024)
Historical FCF Generation Index trend for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 22 annual periods. For the full cash flow conversion analysis, see Tianjin Zhongxin Pharmaceutical Group Co cash flow conversion.
Annual Free Cash Flow Generation for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year Free Cash Flow Generation Index for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. Check Tianjin Zhongxin Pharmaceutical Group Co cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.87x | CN¥806.86 Million | CN¥924.67 Million | CN¥117.81 Million | ▲ +9.7% |
| 2023 | 0.80x | CN¥547.56 Million | CN¥688.49 Million | CN¥140.93 Million | ▼ -5.4% |
| 2022 | 0.84x | CN¥569.34 Million | CN¥677.25 Million | CN¥107.90 Million | ▲ +3.0% |
| 2021 | 0.82x | CN¥695.45 Million | CN¥852.40 Million | CN¥156.95 Million | ▲ +13.6% |
| 2020 | 0.72x | CN¥482.26 Million | CN¥671.42 Million | CN¥189.16 Million | ▲ +22.8% |
| 2019 | 0.59x | CN¥289.87 Million | CN¥495.49 Million | CN¥205.61 Million | ▲ +17.5% |
| 2018 | 0.50x | CN¥174.34 Million | CN¥350.14 Million | CN¥175.81 Million | ▼ -31.2% |
| 2016 | 0.72x | CN¥303.70 Million | CN¥419.90 Million | CN¥116.20 Million | ▼ -2.7% |
| 2015 | 0.74x | CN¥267.94 Million | CN¥360.58 Million | CN¥92.64 Million | ▼ -1.6% |
| 2014 | 0.76x | CN¥216.70 Million | CN¥286.85 Million | CN¥70.15 Million | ▲ +14.3% |
| 2013 | 0.66x | CN¥141.01 Million | CN¥213.44 Million | CN¥72.42 Million | ▲ +167.5% |
| 2012 | -0.98x | CN¥-20.37 Million | CN¥20.81 Million | CN¥41.18 Million | ▼ -230.0% |
| 2011 | 0.75x | CN¥130.86 Million | CN¥173.88 Million | CN¥43.02 Million | ▲ +49.0% |
| 2010 | 0.51x | CN¥70.25 Million | CN¥139.04 Million | CN¥68.79 Million | ▲ +1364.5% |
| 2009 | -0.04x | CN¥-3.33 Million | CN¥83.41 Million | CN¥86.74 Million | ▼ -105.3% |
| 2008 | 0.75x | CN¥117.40 Million | CN¥155.77 Million | CN¥38.36 Million | ▲ +145.2% |
| 2007 | -1.67x | CN¥-33.60 Million | CN¥20.13 Million | CN¥53.74 Million | ▼ -490.0% |
| 2005 | 0.43x | CN¥112.11 Million | CN¥261.91 Million | CN¥149.80 Million | ▲ +101.9% |
| 2004 | -23.04x | CN¥-241.81 Million | CN¥10.50 Million | CN¥252.31 Million | ▼ -244.1% |
| 2003 | -6.70x | CN¥-512.63 Million | CN¥76.57 Million | CN¥589.20 Million | ▼ -17523.4% |
| 2002 | 0.04x | CN¥7.21 Million | CN¥187.60 Million | CN¥180.40 Million | ▼ -74.5% |
| 2001 | 0.15x | CN¥23.77 Million | CN¥157.73 Million | CN¥133.95 Million | — |